This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Doctolib's fine in France for purchase of rival raises antitrust policy questions

By Jean Comte ( November 28, 2025, 13:21 GMT | Comment) -- The French competition watchdog's decision to fine Doctolib, the leading online medical appointment booking platform, over its acquisition of a rival seven years ago is raising questions about where the line is drawn on antitrust rules and market dominance. Doctolib's plans to appeal the penalty suggest it will be for the courts to decide.The French competition watchdog's decision to fine Doctolib over its takeover of a rival seven years ago is raising questions about where the line is drawn on antitrust rules and market dominance. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login